Scaling Allo with Allogene Therapeutics' Dr. Zachary Roberts
Cell & Gene: The Podcast
00:00
Intro
This chapter explores the complexities of managing chronic lymphocytic leukemia (CLL) and the limitations of current CAR T therapies. It emphasizes the ongoing unmet needs in treatment, particularly for refractory patients, and discusses the implications of treatment failures on patient outcomes.
Transcript
Play full episode
